Linghao Zhao

817 total citations
27 papers, 564 citations indexed

About

Linghao Zhao is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Linghao Zhao has authored 27 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Epidemiology and 7 papers in Hepatology. Recurrent topics in Linghao Zhao's work include Hepatitis B Virus Studies (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Linghao Zhao is often cited by papers focused on Hepatitis B Virus Studies (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Linghao Zhao collaborates with scholars based in China, United States and Hong Kong. Linghao Zhao's co-authors include Weiping Zhou, Yuan Yang, Zhenguang Wang, Wan Yee Lau, Weiping Zhou, Gang Huang, Pengpeng Li, Meng‐chao Wang, Ze‐Ya Pan and He‐Xin Yan and has published in prestigious journals such as Bioinformatics, Annals of Surgery and Scientific Reports.

In The Last Decade

Linghao Zhao

27 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linghao Zhao China 13 229 174 172 162 91 27 564
Qianwei Ye China 11 253 1.1× 119 0.7× 219 1.3× 77 0.5× 126 1.4× 15 511
Gianmarco Villano Italy 13 187 0.8× 99 0.6× 115 0.7× 114 0.7× 49 0.5× 28 426
Verena Köberle Germany 15 546 2.4× 163 0.9× 443 2.6× 194 1.2× 82 0.9× 19 898
Caecilia Sukowati Italy 16 429 1.9× 222 1.3× 202 1.2× 197 1.2× 227 2.5× 47 848
Runzhou Zhuang China 12 200 0.9× 71 0.4× 100 0.6× 61 0.4× 55 0.6× 21 393
Yu Wen China 9 168 0.7× 168 1.0× 98 0.6× 94 0.6× 175 1.9× 17 622
Yantao Chai China 11 276 1.2× 108 0.6× 207 1.2× 41 0.3× 160 1.8× 19 551
Devis Pascut Italy 15 369 1.6× 76 0.4× 259 1.5× 78 0.5× 70 0.8× 35 578
C. Papadimitriou Greece 9 203 0.9× 100 0.6× 85 0.5× 95 0.6× 241 2.6× 16 513
Huiwei Sun China 16 388 1.7× 127 0.7× 280 1.6× 53 0.3× 249 2.7× 24 783

Countries citing papers authored by Linghao Zhao

Since Specialization
Citations

This map shows the geographic impact of Linghao Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linghao Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linghao Zhao more than expected).

Fields of papers citing papers by Linghao Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linghao Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linghao Zhao. The network helps show where Linghao Zhao may publish in the future.

Co-authorship network of co-authors of Linghao Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Linghao Zhao. A scholar is included among the top collaborators of Linghao Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linghao Zhao. Linghao Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Jun, et al.. (2024). Glutathione and acid dual-responsive bismuth-based nanosensitizer for chemo-mediated cancer sonodynamic therapy. Biomedical Materials. 19(4). 45035–45035. 1 indexed citations
2.
Guo, Mengbiao, Linghao Zhao, Changchang Jia, et al.. (2023). Multiomics analyses reveal pathological mechanisms of HBV infection and integration in liver cancer. Journal of Medical Virology. 95(8). e28980–e28980. 4 indexed citations
3.
Sun, Dapeng, Xiaojie Gan, Lei Liu, et al.. (2022). DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334. Cell Death and Disease. 13(5). 446–446. 16 indexed citations
4.
Zhao, Linghao, Tian Tao, Wei Dong, et al.. (2022). Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma. Hepatology International. 16(6). 1339–1352. 8 indexed citations
5.
Tian, Tao, Feng Xiao, Hongdong Li, et al.. (2021). Association between serum iron status and primary liver cancer risk: a Mendelian randomization analysis. Annals of Translational Medicine. 9(20). 1533–1533. 9 indexed citations
6.
Zeng, Xi, et al.. (2021). HIVID2: an accurate tool to detect virus integrations in the host genome. Bioinformatics. 37(13). 1821–1827. 5 indexed citations
7.
Yang, Yun, Xiaofei Zhu, Jian Huang, et al.. (2021). Nomogram for prediction of fatal outcome in patients with severe COVID-19: a multicenter study. Military Medical Research. 8(1). 21–21. 11 indexed citations
8.
Wang, Minjun, Shaohua Song, Jing Su, et al.. (2021). Inhibition of SIRT1 Limits Self-Renewal and Oncogenesis by Inducing Senescence of Liver Cancer Stem Cells. Journal of Hepatocellular Carcinoma. Volume 8. 685–699. 15 indexed citations
9.
10.
Xu, Qingguo, Shengxian Yuan, Qi-fei Tao, et al.. (2019). A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinoma. Journal of Hepatology. 70(5). 904–917. 20 indexed citations
11.
Chen, Jiajia, Tao Yang, Shaohua Song, et al.. (2019). Senescence suppressed proliferation of host hepatocytes is precondition for liver repopulation. Biochemical and Biophysical Research Communications. 516(2). 591–598. 5 indexed citations
12.
Qin, Chenjie, Linghao Zhao, Xu Zhou, et al.. (2018). Inhibition of dipeptidyl peptidase IV prevents high fat diet-induced liver cancer angiogenesis by downregulating chemokine ligand 2. Cancer Letters. 420. 26–37. 48 indexed citations
13.
Huang, Gang, Pengpeng Li, Wan Yee Lau, et al.. (2018). Antiviral Therapy Reduces Hepatocellular Carcinoma Recurrence in Patients With Low HBV-DNA Levels. Annals of Surgery. 268(6). 943–954. 94 indexed citations
14.
Qin, Chenjie, Linghao Zhao, Min Zeng, et al.. (2017). Microbiota transplantation reveals beneficial impact of berberine on hepatotoxicity by improving gut homeostasis. Science China Life Sciences. 61(12). 1537–1544. 16 indexed citations
15.
Yang, Yuan, Linghao Zhao, Bo Huang, et al.. (2017). A New Approach to Evaluating Aberrant DNA Methylation Profiles in Hepatocellular Carcinoma as Potential Biomarkers. Scientific Reports. 7(1). 46533–46533. 6 indexed citations
16.
Zhang, Hui‐Lu, Ming-Da Wang, Xu Zhou, et al.. (2016). Blocking preferential glucose uptake sensitizes liver tumor-initiating cells to glucose restriction and sorafenib treatment. Cancer Letters. 388. 1–11. 45 indexed citations
17.
Yang, Yun, Jin Zhang, Tian Xia, et al.. (2016). MicroRNA-210 promotes cancer angiogenesis by targeting fibroblast growth factor receptor-like 1 in hepatocellular carcinoma. Oncology Reports. 36(5). 2553–2562. 54 indexed citations
18.
Yang, Hongxia, Linghao Zhao, Jinxu Gao, Wei Liu, & Bing Li. (2014). Bioimaging and Distribution of Cd,P, S, K, Ca,Cu and Zn Elements in Indian Mustard Stem. Chinese Journal of Analytical Chemistry. 42(3). 355–359. 10 indexed citations
19.
Cao, Jie, Xiaoling Liao, Shichao Wu, et al.. (2006). Selection of a phage-displayed peptide recognized by monoclonal antibody directed blocking the site of hepatitis C virus E2 for human CD81. Journal of Microbiological Methods. 68(3). 601–604. 14 indexed citations
20.
Cao, Jinping, et al.. (2003). Identification and expression of human CD81 gene on murine NIH/3T3 cell membrane. Journal of Microbiological Methods. 54(1). 81–85. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026